Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If You Use a Screen Reader

This content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.

Link between D1 and D2 Dopamine Receptors is Reduced in Schizophrenia and Huntington Diseased Brain

Philip Seeman, Hyman B. Niznik, H.-C. Guan, Gillian Booth and Carla Ulpian
Proceedings of the National Academy of Sciences of the United States of America
Vol. 86, No. 24 (Dec. 15, 1989), pp. 10156-10160
Stable URL: http://www.jstor.org/stable/34820
Page Count: 5
  • Read Online (Free)
  • Subscribe ($19.50)
  • Cite this Item
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Link between D1 and D2 Dopamine Receptors is Reduced in Schizophrenia and Huntington Diseased Brain
Preview not available

Abstract

Dopamine receptor types D1 and D2 can oppose or enhance each other's actions for electrical, biochemical, and psychomotor effects. We report a D1-D2 interaction in homogenized tissue as revealed by ligand binding. D2 agonists lowered the binding of [3H]raclopride to D2 receptors in striatal and anterior pituitary tissues. Pretreating the tissue with the D1-selective antagonist SCH 23390 prevented the agonistinduced decrease in [3H]raclopride binding to D2 sites in the striatum but not in the anterior pituitary, which has no D1 receptors. Conversely, a dopamine-induced reduction in the binding of [3H]SCH 23390 to D1 receptors could be prevented by the D2-selective antagonist eticlopride. Receptor photolabeling experiments confirmed both these D1-D2 interactions. The blocking effect by SCH 23390 was similar to that produced by a nonhydrolyzable guanine nucleotide analogue, and SCH 23390 reduced the number of agonist-labeled D2 receptors in the high-affinity state. Thus, the D1-D2 link may be mediated by guanine nucleotide-binding protein components. The link may underlie D1-D2 interactions influencing behavior, since the link was missing in over half the postmortem striata from patients with schizophrenia and Huntington disease (both diseases that show some hyperdopamine signs) but was present in human control, Alzheimer, and Parkinson striata.

Page Thumbnails

  • Thumbnail: Page 
10156
    10156
  • Thumbnail: Page 
10157
    10157
  • Thumbnail: Page 
10158
    10158
  • Thumbnail: Page 
10159
    10159
  • Thumbnail: Page 
10160
    10160